Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years

Sci Rep. 2022 Nov 27;12(1):20373. doi: 10.1038/s41598-022-24409-w.

Abstract

Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65-84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related effect, with lower increase in those infected before a single dose of primary vaccination. Of note, humoral response was observed only starting from the 5th day after the boost.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19* / prevention & control
  • Humans
  • Neutralization Tests
  • RNA, Messenger
  • SARS-CoV-2 / genetics
  • Vaccination
  • Viral Vaccines*

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • RNA, Messenger
  • Viral Vaccines

Supplementary concepts

  • SARS-CoV-2 variants
  • COVID-19 vaccine booster shot